Seeking Alpha

Siemens to sell microbiology business to Danaher

  • As part of a restructuring plan, Siemens (OTCPK:SIEGY) has announced it will sell its microbiology unit to Beckman Coulter, a subsidiary of Danaher (NYSE:DHR). The deal will allow Siemens to concentrate more on its healthcare division's in-vitro business.
  • The transaction is expected to close in the first quarter of 2015.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|